Millennium Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $459M | Buy |
498,500
+10,300
| +2% | +$10.4M | 0.19% | 76 |
|
|
2025
Q4 | $525M | Buy |
488,200
+56,800
| +13% | +$54.3M | 0.22% | 57 |
|
|
2025
Q3 | $329M | Buy |
431,400
+86,400
| +25% | +$64.3M | 0.14% | 92 |
|
|
2025
Q2 | $269M | Buy |
345,000
+42,300
| +14% | +$32.9M | 0.13% | 115 |
|
|
2025
Q1 | $250M | Sell |
302,700
-35,700
| -11% | -$29.7M | 0.13% | 106 |
|
|
2024
Q4 | $261M | Sell |
338,400
-48,000
| -12% | -$39.7M | 0.13% | 115 |
|
|
2024
Q3 | $342M | Sell |
386,400
-248,300
| -39% | -$223M | 0.16% | 75 |
|
|
2024
Q2 | $575M | Buy |
634,700
+209,100
| +49% | +$167M | 0.27% | 44 |
|
|
2024
Q1 | $331M | Buy |
425,600
+28,800
| +7% | +$20.5M | 0.14% | 94 |
|
|
2023
Q4 | $231M | Sell |
396,800
-179,300
| -31% | -$105M | 0.1% | 147 |
|
|
2023
Q3 | $309M | Sell |
576,100
-39,000
| -6% | -$20.1M | 0.16% | 77 |
|
|
2023
Q2 | $288M | Buy |
615,100
+514,600
| +512% | +$216M | 0.14% | 80 |
|
|
2023
Q1 | $34.5M | Sell |
100,500
-612,600
| -86% | -$207M | 0.02% | 932 |
|
|
2022
Q4 | $261M | Buy |
713,100
+222,800
| +45% | +$79M | 0.14% | 92 |
|
|
2022
Q3 | $159M | Sell |
490,300
-8,800
| -2% | -$2.79M | 0.09% | 160 |
|
|
2022
Q2 | $162M | Buy |
499,100
+23,700
| +5% | +$7.11M | 0.1% | 129 |
|
|
2022
Q1 | $136M | Sell |
475,400
-281,200
| -37% | -$72.4M | 0.07% | 227 |
|
|
2021
Q4 | $209M | Buy |
756,600
+190,300
| +34% | +$48.2M | 0.11% | 145 |
|
|
2021
Q3 | $131M | Buy |
566,300
+7,700
| +1% | +$1.9M | 0.08% | 219 |
|
|
2021
Q2 | $128M | Buy |
558,600
+262,700
| +89% | +$52.8M | 0.08% | 215 |
|
|
2021
Q1 | $55.3M | Buy |
295,900
+137,900
| +87% | +$27M | 0.04% | 449 |
|
|
2020
Q4 | $26.7M | Buy |
158,000
+15,700
| +11% | +$2.34M | 0.02% | 855 |
|
|
2020
Q3 | $21.1K | Buy |
142,300
+32,700
| +30% | +$5.06M | 0.03% | 767 |
|
|
2020
Q2 | $18M | Sell |
109,600
-131,500
| -55% | -$20.2M | 0.02% | 803 |
|
|
2020
Q1 | $33.4M | Buy |
241,100
+141,100
| +141% | +$19.4M | 0.08% | 267 |
|
|
2019
Q4 | $13.1M | Buy |
100,000
+95,600
| +2,173% | +$11.1M | 0.02% | 1147 |
|
|
2019
Q3 | $492K | Buy |
+4,400
| New | +$490K | ﹤0.01% | 3270 |
|
|
2018
Q4 | – | Sell |
-200,000
| Closed | -$21.5M | – | 3980 |
|
|
2018
Q3 | $21.5M | Buy |
+200,000
| New | +$20M | 0.03% | 815 |
|
|
2017
Q1 | – | Sell |
-100,000
| Closed | -$7.36M | – | 3683 |
|
|
2016
Q4 | $7.36M | Buy |
100,000
+51,500
| +106% | +$3.84M | 0.02% | 1094 |
|
|
2016
Q3 | $3.89M | Buy |
+48,500
| New | +$3.88M | 0.01% | 1501 |
|
|
2014
Q4 | – | Sell |
-4,400
| Closed | -$285K | – | 4121 |
|
|
2014
Q3 | $285K | Sell |
4,400
-6,200
| -58% | -$393K | ﹤0.01% | 3121 |
|
|
2014
Q2 | $659K | Buy |
+10,600
| New | +$632K | ﹤0.01% | 2428 |
|
|
2013
Q4 | – | Sell |
-275,800
| Closed | -$13.9M | – | 3619 |
|
|
2013
Q3 | $13.9M | Buy |
+275,800
| New | +$14.4M | 0.04% | 532 |
|
Other funds holding LLY
VCM
VPM
Millennium Management's LLY Position: Q1 2026 in Review
Millennium Management reduced its Eli Lilly (LLY) stake by 18% in Q1 2026, selling an estimated $59.7M and leaving 275,989 shares worth $254M. The position accounts for 0.11% of the portfolio, ranked #165.
Millennium Management first reported a position in LLY in Q2 2013 and has held it in 50 quarters since. The position peaked at $877M in Q3 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Millennium Management held 275,989 shares of Eli Lilly worth $254M as of Q1 2026.
- Millennium Management sold 58,869 Eli Lilly shares in Q1 2026, an estimated $59.7M.
- Eli Lilly made up 0.11% of Millennium Management's portfolio in Q1 2026, its #165 holding.
- Millennium Management first reported a position in Eli Lilly in Q2 2013 and has held it in 50 quarters since.
- Millennium Management's Eli Lilly position peaked at $877M in Q3 2024.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.